Ixabepilone, a novel epothilone analog in the treatment of breast cancer

作者:Pivot Xavier*; Villanueva Christian; Chaigneau Loic; Nguyen Thierry; Demarchi Martin; Maurina Tristan; Stein Ulrich; Borg Christophe
来源:Expert Opinion on Investigational Drugs, 2008, 17(4): 593-599.
DOI:10.1517/13543784.17.4.593

摘要

Background: Natural epothilones and their analogs promote tumor cell death by binding to tubulin and stabilizing microtubules, causing cell death. Ixabepilone (BMS-247550, Ixempra (R)) is an epothilone analog that optimizes the properties naturally observed with epothilone B. Objective: To provide an overview of the results achieved by ixabepilone in metastatic breast cancer. Methods: A PubMed search was performed to provide an extensive review of all published data on ixabepilone, in addition to all data reported from international congresses, from 2003 to 2007. Results/conclusion: There is a clear need for new agents active against resistant metastatic breast cancer and ixabepilone might be a welcome new compound in this situation.

  • 出版日期2008-4